Therapeutic Drug Monitoring of Ganciclovir: Where Are We?

Ganciclovir is the mainstay of therapy for the prophylaxis and treatment of Cytomegalovirus. However, therapy with this antiviral agent is hindered by side effects such as myelosuppression, which often leads to therapy cessation. Underdosing, as an attempt to prevent side effects, can lead to drug r...

Descripción completa

Detalles Bibliográficos
Autores principales: Märtson, Anne-Grete, Edwina, Angela E., Kim, Hannah Yejin, Knoester, Marjolein, Touw, Daan J., Sturkenboom, Marieke G. G., Alffenaar, Jan-Willem C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Therapeutic Drug Monitoring 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746890/
https://www.ncbi.nlm.nih.gov/pubmed/34610621
http://dx.doi.org/10.1097/FTD.0000000000000925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746890/
https://www.ncbi.nlm.nih.gov/pubmed/34610621
http://dx.doi.org/10.1097/FTD.0000000000000925

Ejemplares similares